PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA

OXFORD, Ohio and COCONUT CREEK, Fla., April 26, 2021 /CNW/ — PsyBio Therapeutics Corp. (TSXV: PSYB) (“PsyBio” or the “Company“), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces today that it has amended its master sponsored agreement with Miami University based in Oxford, Ohio (the “Amended Agreement“) to extend and expand the research efforts…

Source